Discontinuation report INVIRASE - CAP 200MG
| Report ID | 53093 |
| Drug Identification Number | 02216965 |
| Brand name | INVIRASE - CAP 200MG |
| Common or Proper name | Saquinavir mesylate (Invirase) |
| Company Name | HOFFMANN-LA ROCHE LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | SAQUINAVIR |
| Strength(s) | 200MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 270 pills/pack |
| ATC code | J05AE |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-12-31 |
| Actual discontinuation date | |
| Remaining supply date | 2018-12-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-06-28 | English | Compare |
| v2 | 2018-06-28 | English | Compare |
| v3 | 2018-06-28 | French | Compare |
Showing 1 to 3 of 3